| Literature DB >> 31744994 |
Ying Li1, Ting Zhou2, Yu-Fang Su1, Zhi-Yong Hu1, Jia-Jing Wei1, Wei Wang1, Chun-Yan Liu1, Kai Zhao1, Hui-Ping Zhang1.
Abstract
Varicocele is one of the most important causes of male infertility, as this condition leads to a decline in sperm quality. It is generally believed that the presence of varicocele induces an increase in reactive oxygen species levels, leading to oxidative stress and sperm apoptosis; however, the specific pathogenic mechanisms affecting spermatogenesis remain elusive. Prokineticin 2 (PK2), a secretory protein, is associated with multiple biological processes, including cell migration, proliferation, and apoptosis. In the testis, PK2 is expressed in spermatocytes under normal physiological conditions. To investigate the role of PK2 in varicocele, a rat varicocele model was established to locate and quantify the expression of PK2 and its receptor, prokineticin receptor 1 (PKR1), by immunohistochemistry and quantitative real-time PCR assays (qPCR). Moreover, H2O2 was applied to mimic the oxidative stress state of varicocele through coculturing with a spermatocyte-derived cell line (GC-2) in vitro, and the apoptosis rate was detected by flow cytometry. Here, we illustrated that the expression levels of PK2 and PKR1 were upregulated in the spermatocytes of the rat model. Administration of H2O2 stimulated the overexpression of PK2 in GC-2. Transfection of recombinant pCMV-HA-PK2 into GC-2 cells promoted apoptosis by upregulating cleaved-caspase-3, caspase-8, and B cell lymphoma 2-associated X; downregulating B cell lymphoma 2; and promoting the accumulation of intracellular calcium. Overall, we revealed that the varicocele-induced oxidative stress stimulated the overexpression of PK2, leading to apoptosis of spermatocytes. Our study provides new insight into the mechanisms underlying oxidative stress-associated male infertility and suggests a novel therapeutic target for male infertility.Entities:
Keywords: apoptosis; oxidative stress; prokineticin 2; varicocele
Mesh:
Substances:
Year: 2020 PMID: 31744994 PMCID: PMC7523614 DOI: 10.4103/aja.aja_109_19
Source DB: PubMed Journal: Asian J Androl ISSN: 1008-682X Impact factor: 3.285
Figure 3PK2 expression and oxidative stress in GC-2 cells. GC-2 cells were cocultured with various concentrations of H2O2 (0, 200, 400, and 600 μmol l−1) for 6 h. (a) The basal expression levels of PK2 and PKR1 in GC-2 cells were determined by immunofluorescence. The scale bars represent 100 μm. (b) The viability of GC-2 cells in the different groups was determined by CCK8 assay. (c) Alterations in the mRNA expression of PK2 in GC-2 cells in the different groups were determined by qPCR. (d) Alteration of the protein expression of PK2 in GC-2 cells in the different groups was analyzed by Western blot. All experiments were replicated in three independent experiments from different cell samples. Each treatment group was compared with the control group, *P < 0.05, **P < 0.01, ***P < 0.001 (one-way ANOVA). PK2: prokineticin 2; PKR1: prokineticin receptor 1; qPCR: quantitative real-time PCR assays; ANOVA: analysis of variance.
Figure 4Overexpression of PK2 and GC-2 apoptosis. GC-2 cells were either transfected with various concentrations of the pCMV-HA-PK2 plasmid (4 μg and 8 μg), or empty vector plasmid for 48 h as a control. (a) The apoptosis rate was quantified by flow cytometry of GC-2 cells labeled with Annexin V-FITC and PI. (b) Cell viability in the different groups with various concentrations of plasmid was determined by CCK8 assay. (c) The cell lysates were analyzed by Western blotting with antibodies against cleaved-caspase-3, caspase-8, Bax, and Bcl-2. (d) The concentrations of intracellular calcium of GC-2 cells were determined by immunofluorescence. The scale bars represent 100 μm. All experiments were replicated in three independent experiments from different cell samples. Con: the cells were transfected with an empty vector. Each treatment group was compared with the control group, **P < 0.01 (one-way ANOVA). PK2: prokineticin 2; Bax: B cell lymphoma 2-associated X; Bcl-2: B cell lymphoma 2; ANOVA: analysis of variance.
Quantitative polymerase chain reaction primer sequences
| Forward | CAAGGACTCTCAGTGTGGA | 128 | |
| Reverse | AAAATGGAACTTTCCGAGTC | ||
| Forward | TGGGCGAGAATACCACAA | 182 | |
| Reverse | GCCATGCCAATGACAATC | ||
| Forward | GATGAGATTGGCATGGCTTT | 101 | |
| Reverse | CACCTTCACCGTTCCAGTTT |
PK2: prokineticin 2; PKR1: prokineticin receptor 1
Statistical analysis of in vivo experiment
| SOD (U/mg protein) | 4.1±0.4 | 2.3±0.4 | 1 |
| MDA (µmol/mg protein) | 10.3±1.2 | 18.3±2.1 | 1 |
| Sperm total number/108 | 2.3±0.3 | 2.0±0.3 | 1 |
| Progressive sperm motility (%) | 50.7±3.1 | 36.7±5.9 | 1 |
| Relative expression of PK2 | 1.0 | 1.8±0.2 | 2 |
| Relative expression of PKR1 | 1.0 | 2.4±0.3 | 3 |
PK2: prokineticin 2; PKR1: prokineticin receptor 1; SOD: superoxide dismutase; MDA: malondialdehyde
Statistical analysis of Figure 3
| Relative expression of PK2 | 1 | 1.8±0.5 | 2.3±0.1 | – |
| Cells viability (%) | 91.8±2.8 | 81.1±3.6 | 49.7±3.0 | 22.6±1.9 |
PK2: prokineticin 2
Statistical analysis of Figure 4
| Cells viability (%) | 95.9±2.5 | 83.2±2.2 | 75.4±3.7 |